Thymoma laboratory tests

Jump to navigation Jump to search

Thymoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thymoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thymoma laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thymoma laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thymoma laboratory tests

CDC on Thymoma laboratory tests

Thymoma laboratory tests in the news

Blogs on Thymoma laboratory tests

Directions to Hospitals Treating Thymoma

Risk calculators and risk factors for Thymoma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2] Ahmad Al Maradni, M.D. [3]

Overview

Laboratory findings associated with thymoma may include antibodies against the acetylcholine receptor, abnormal electrolytes, renal, and liver function tests.

Laboratory Findings

Patients with thymoma can have the following laboratory findings:[1]

References

  1. Thomas CR, Wright CD, Loehrer PJ (1999). "Thymoma: state of the art". Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17 (7): 2280–9. PMID 10561285. Retrieved 2012-01-18. Unknown parameter |month= ignored (help)
  2. Y. Jamilloux, H. Frih, C. Bernard, C. Broussolle, P. Petiot, N. Girard & P. Seve (2018). "[Thymoma and autoimmune diseases]". La Revue de medecine interne. 39 (1): 17–26. doi:10.1016/j.revmed.2017.03.003. PMID 28365191. Unknown parameter |month= ignored (help)
  3. Shin Hye Yoo, Hyean-Ji Kim, Jeong-Han Kim, Gyeong-Won Lee, Jeong Hee Lee, Se Hyun Kim, Ji-Won Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang & Jong Seok Lee (2017). "Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy". Medicine. 96 (1): e5408. doi:10.1097/MD.0000000000005408. PMID 28072685. Unknown parameter |month= ignored (help)
  4. Shin Hye Yoo, Hyean-Ji Kim, Jeong-Han Kim, Gyeong-Won Lee, Jeong Hee Lee, Se Hyun Kim, Ji-Won Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang & Jong Seok Lee (2017). "Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy". Medicine. 96 (1): e5408. doi:10.1097/MD.0000000000005408. PMID 28072685. Unknown parameter |month= ignored (help)
  5. Tomoki Nishimura, Hiroaki Tsunezuka, Naoko Miyata & Masayoshi Inoue (2019). "Autoimmune hepatitis during preoperative chemotherapy in a patient with thymoma". Interactive cardiovascular and thoracic surgery. doi:10.1093/icvts/ivz138. PMID 31177282. Unknown parameter |month= ignored (help)

Template:WikiDoc Sources